Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamdouh M Ali

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Bioorganic Chemistry|July 18, 2018
Tetrahydroindolocarbazoles (THICZs) as new class of urokinase (uPA) inhibitors: Synthesis, anticancer evaluation, DNA-damage determination, and molecular modelling studyMarwa A M Sh El-Sharief, Mohamed H El-Naggar, Entesar M Ahmed, et al.
Bioorganic Chemistry|September 24, 2024
Design, synthesis, and in silico insights of novel N'-(2-oxoindolin-3-ylidene)piperidine-4-carbohydrazide derivatives as VEGFR-2 inhibitorsWagdy M Eldehna, Youmna A Habib, Abeer E Mahmoud, et al.
Bioorganic Chemistry|October 9, 2019
Towards breast cancer targeting: Synthesis of tetrahydroindolocarbazoles, antibreast cancer evaluation, uPA inhibition, molecular genetic and molecular modelling studiesEntesar M Ahmed, Alaadin E Sarhan, Dina H El-Naggar, et al.
European Journal of Medicinal Chemistry|April 24, 2017
Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugsShadia A Galal, Ahmed S Abdelsamie, Samia A Shouman, et al.
European Journal of Medicinal Chemistry|January 10, 2018
Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitorsShadia A Galal, Sarah H M Khairat, Hamed I Ali, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Bioorganic Chemistry|July 18, 2018
Tetrahydroindolocarbazoles (THICZs) as new class of urokinase (uPA) inhibitors: Synthesis, anticancer evaluation, DNA-damage determination, and molecular modelling studyMarwa A M Sh El-Sharief, Mohamed H El-Naggar, Entesar M Ahmed, et al.
Bioorganic Chemistry|September 24, 2024
Design, synthesis, and in silico insights of novel N'-(2-oxoindolin-3-ylidene)piperidine-4-carbohydrazide derivatives as VEGFR-2 inhibitorsWagdy M Eldehna, Youmna A Habib, Abeer E Mahmoud, et al.
Bioorganic Chemistry|October 9, 2019
Towards breast cancer targeting: Synthesis of tetrahydroindolocarbazoles, antibreast cancer evaluation, uPA inhibition, molecular genetic and molecular modelling studiesEntesar M Ahmed, Alaadin E Sarhan, Dina H El-Naggar, et al.
European Journal of Medicinal Chemistry|April 24, 2017
Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugsShadia A Galal, Ahmed S Abdelsamie, Samia A Shouman, et al.
European Journal of Medicinal Chemistry|January 10, 2018
Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitorsShadia A Galal, Sarah H M Khairat, Hamed I Ali, et al.
Pageof 6